Skip to main content
Top
Literature
1.
go back to reference Gold R, Comi G, Palace J, Siever A, Gottschalk R, Bijarnia M, von Rosenstiel P, Tomic D, Kappos L (2013) Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study. J Neurol. doi:10.1007/s00415-013-7115-8 PubMedCentral Gold R, Comi G, Palace J, Siever A, Gottschalk R, Bijarnia M, von Rosenstiel P, Tomic D, Kappos L (2013) Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study. J Neurol. doi:10.​1007/​s00415-013-7115-8 PubMedCentral
4.
go back to reference Bakshi R, Karan R. Novartis Pharma, data on file Bakshi R, Karan R. Novartis Pharma, data on file
Metadata
Title
Ventricular arrhythmia in a male MS patient on fingolimod
Authors
Vincent van Pesch
Sébastien Marchandise
Souraya El Sankari
Christian Sindic
Publication date
01-03-2015
Publisher
Springer Milan
Published in
Acta Neurologica Belgica / Issue 1/2015
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-014-0297-8

Other articles of this Issue 1/2015

Acta Neurologica Belgica 1/2015 Go to the issue